Biolife Solutions
BLFS
Operating Margin for Biolife Solutions (BLFS)
Operating Margin as of May 2024 (TTM): -23.29%
According to Biolife Solutions 's latest financial reports and stock price the company's current Operating Margin is -23.29%. At the end of 2021 the company had an Operating Margin of -23.29%.
Operating Margin history for Biolife Solutions from 2001 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -23.29% | 1776.06% |
| 2020 | -1.24% | -89.37% |
| 2019 | -11.68% | -170.63% |
| 2018 | 16.54% | -172.5% |
| 2017 | -22.82% | -76.65% |
| 2016 | -97.74% | 26.18% |
| 2015 | -77.46% | 45.28% |
| 2014 | -53.32% | 340.13% |
| 2013 | -12.11% | -58.66% |
| 2012 | -29.31% | -58.68% |
| 2011 | -70.93% | 5.89% |
| 2010 | -66.98% | -61.73% |
| 2009 | -175.03% | -6.03% |
| 2008 | -186.27% | -36.49% |
| 2007 | -293.31% | 56.02% |
| 2006 | -187.99% | 86.6% |
| 2005 | -100.75% | -15.04% |
| 2004 | -118.58% | -44.91% |
| 2003 | -215.25% | 186.36% |
| 2002 | -75.17% | -77.04% |
| 2001 | -327.42% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Celanese CE | 5.71% | -124.52% | 🇺🇸 USA |
 Enanta Pharmaceuticals
ENTA | -158.97% | 582.57% | 🇺🇸 USA |
 Amyris AMRS | -79.66% | 242.04% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.